Medline (MDLN) Payables (2024 - 2026)

Medline (MDLN) has reported Payables for 3 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables changed N/A year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $961.0 million, up 10.59% from the prior year.
• Payables was $1.0 billion for Q2 2026 at Medline, up from $932.0 million in the prior quarter.
• Over five years, Payables peaked at $1.0 billion in Q2 2026 and troughed at $869.0 million in Q4 2024.
• A 3-year average of $951.2 million and a median of $946.5 million in 2025 frame the typical range for Payables.
• The widest YoY moves for Payables: up 10.59% in 2025, down 10.59% in 2025.
• Over 3 years, Payables stood at $869.0 million in 2024, then advanced by 10.59% to $961.0 million in 2025, then increased by 8.53% to $1.0 billion in 2026.
• The last three Payables figures came in at $1.0 billion (Q2 2026), $932.0 million (Q1 2026), and $961.0 million (Q4 2025), per Business Quant data.